購(gòu)物車(chē)
幫助
021-54845833/15800441009
中文名稱(chēng) : 小鼠抗F13A1單克隆抗體
|
Background: |
This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]. |
|
Applications: |
WB, IHC |
|
Name of antibody: |
F13A1 |
|
Immunogen: |
Fusion protein of human F13A1 |
|
Full name: |
coagulation factor XIII, A1 polypeptide (F13A1) |
|
Synonyms: |
F13A |
|
SwissProt: |
P00488 |
|
IHC positive control: |
carcinoma of human bladder tissue and human lymph node tissue |
|
IHC Recommend dilution: |
30-150 |
|
WB Predicted band size: |
83 kDa |
|
WB Positive control: |
A549 cell lysate |
|
WB Recommended dilution: |
500-2000 |
